GROWTH-HORMONE (GH) SECRETION IN ACTIVE ACROMEGALY AFTER THE COMBINED ADMINISTRATION OF GH-RELEASING HORMONE AND GH-RELEASING PEPTIDE-6

被引:26
|
作者
POPOVIC, V
DAMJANOVIC, S
MICIC, D
PETAKOV, M
DIEGUEZ, C
CASANUEVA, FF
机构
[1] UNIV SANTIAGO DE COMPOSTELA, FAC MED, DEPT PHYSIOL, E-15780 SANTIAGO, SPAIN
[2] UNIV SANTIAGO DE COMPOSTELA, FAC MED, DEPT MED, SANTIAGO, SPAIN
[3] UNIV BELGRADE, CTR CLIN, INST ENDOCRINOL, YU-11000 BELGRADE, YUGOSLAVIA
来源
关键词
D O I
10.1210/jc.79.2.456
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (called GHRP-6) is a synthetic compound that releases GH in a dose-related, specific, and nonspecies-specific manner, through mechanisms different from those of GHRH. Being, normally, more potent than GHRH, GHRP-6 shows a striking synergistic action when administered simultaneously with GHRH, although the mechanisms and point of action of such a potentiating effect are unknown. The aim of the present study was 2-fold: 1) to further characterize the actions and mechanisms of GHRP-6 as well as its synergistic effects, and 2) to study its actions in acromegalic patients. Eleven acromegalic patients and 12 normal subjects, age and sex matched as controls, underwent 3 tests each on separate occasions, being challenged with GHRH (100 mu g, iv), GHRP-6 (90 mu g, iv), or GHRH plus GHRP-6. GH was analyzed as the area under the curve (mean +/- SE; micrograms per L/120 min). In normal subjects, GH secretion was 686 +/- 227 after GHRH, 1787 +/- 510 after GHRP-6, and 4111 +/- 671 after GHRH plus GHRP-6; the level of GH secreted after GHRH plus GHRP-6 treatment was significantly (P < 0.05) higher than the arithmetic sum of GH levels after both compounds administered separately. In acromegalic patients, the level of GH secreted after GHRH was 1468 +/- 499, that after GHRP-6 was 2595 +/- 762, and that after GHRH plus GHRP-6 was 4949 +/- 1043; this last value was not significantly different from the arithmetical addition of levels produced by both compounds administered separately. These results indicate that GH-secreting pituitary adenomas respond surprisingly well to either GHRH or GHRP-6 despite being deprived for long periods (even years) of the physiological regulation exerted by the hypothalamus. In addition, the synergistic action of GHRH plus GHRP-6 was observed in normal subjects, but not in acromegalic patients. These results suggest that GHRP-6 does not need to operate through hypothalamic factors to exert its GH-releasing action, even for eliciting a greater response than GHRH. On the other hand, the synergistic effect of GHRH plus GHRP-6 appears to need the cooperation of the hypothalamus, but how this occurs is still undetermined.
引用
收藏
页码:456 / 460
页数:5
相关论文
共 50 条
  • [11] GROWTH-HORMONE (GH) RESPONSE TO GH-RELEASING HORMONE IN DEPRESSION
    LESCH, KP
    LAUX, G
    PFULLER, H
    ERB, A
    BECKMANN, H
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (06): : 1278 - 1281
  • [12] BROMOCRIPTINE DOES NOT ALTER GROWTH-HORMONE (GH) RESPONSIVENESS TO GH-RELEASING HORMONE IN ACROMEGALY
    COZZI, R
    DALLABONZANA, D
    OPPIZZI, G
    VERDE, G
    LIUZZI, A
    CHIODINI, PG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (03): : 601 - 604
  • [13] Determinants of GH-releasing hormone and GH-releasing peptide synergy in men
    Veldhuis, Johannes D.
    Bowers, Cyril Y.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 296 (05): : E1085 - E1092
  • [14] EFFECTS OF THEOPHYLLINE INFUSION ON THE GROWTH-HORMONE (GH) AND PROLACTIN RESPONSE TO GH-RELEASING HORMONE ADMINISTRATION IN ACROMEGALY
    LOSA, M
    ALBALOPEZ, J
    SCHOPOHL, J
    SOBIESCZCYK, S
    CHIODINI, PG
    MULLER, OA
    VONWERDER, K
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1988, 11 (09) : 663 - 667
  • [15] THE GROWTH-HORMONE (GH) RESPONSE TO GH-RELEASING PEPTIDE (HIS-DTRP-ALA-TRP-DPHE-LYS-NH2), GH-RELEASING HORMONE, AND THYROTROPIN-RELEASING-HORMONE IN ACROMEGALY
    ALSTER, DK
    BOWERS, CY
    JAFFE, CA
    HO, PJ
    BARKAN, AL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (03): : 842 - 845
  • [16] STUDIES ON THE RESPONSE OF GROWTH-HORMONE (GH) SECRETION TO GH-RELEASING HORMONE, THYROTROPIN-RELEASING-HORMONE, GONADOTROPIN-RELEASING-HORMONE, AND SOMATOSTATIN IN ACROMEGALY
    SHIBASAKI, T
    HOTTA, M
    MASUDA, A
    IMAKI, T
    OBARA, N
    HIZUKA, N
    TAKANO, K
    WAKABAYASHI, I
    DEMURA, H
    LING, N
    SHIZUME, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (01): : 167 - 173
  • [17] GROWTH-HORMONE (GH)-RELEASING HORMONE-SECRETION IS STIMULATED BY A NEW GH-RELEASING HEXAPEPTIDE IN SHEEP
    GUILLAUME, V
    MAGNAN, E
    CATALDI, M
    DUTOUR, A
    SAUZE, N
    RENARD, M
    RAZAFINDRAIBE, H
    CONTEDEVOLX, B
    DEGHENGHI, R
    LENAERTS, V
    OLIVER, C
    [J]. ENDOCRINOLOGY, 1994, 135 (03) : 1073 - 1076
  • [18] Effect of exogenous porcine GH administration on GH responses to GH-releasing peptide-2 and GH-releasing hormone in swine
    Nou, V
    Tomoshi, K
    Inoue, H
    Matsunaga, N
    Kuwayama, H
    Hidari, H
    [J]. ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES, 2003, 16 (08): : 1188 - 1192
  • [19] Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency
    Maheshwari, HG
    Rahim, A
    Shalet, SM
    Baumann, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (03): : 956 - 959
  • [20] GROWTH-HORMONE (GH)-RELEASING PEPTIDE STIMULATES GH RELEASE IN NORMAL MEN AND ACTS SYNERGISTICALLY WITH GH-RELEASING HORMONE
    BOWERS, CY
    REYNOLDS, GA
    DURHAM, D
    BARRERA, CM
    PEZZOLI, SS
    THORNER, MO
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04): : 975 - 982